Literature DB >> 30350526

Surgical outcomes among inflammatory bowel disease patients undergoing colectomy : results from a national database.

M A Rahal1, W R Karaoui1, A Mailhac2, H Tamim2, Y Shaib1.   

Abstract

INTRODUCTION: Colectomy is relatively common in inflammatory bowel diseases (IBD), occurring more in Ulcerative Colitis (UC) as compared to Crohn's disease (CD). The surgical outcomes among this mixed population of patients are not well understood. This study aims to determine the predictors of post colectomy surgical outcomes in this patient population.
METHODS: Using the National Surgical Quality Improvement Project (NSQIP) demographics, preoperative and post-operative data were analyzed for all patients undergoing colectomy for either CD or UC. Multiple variables were linked to several outcomes including mortality, anastomotic leak, and reoperation post colectomy.
RESULTS: A total of 5049 IBD patients that underwent colectomy were identified. Rate of reoperation and anastomotic leak were significantly increased with steroid intake with an Odds Ratio (OR) of 1.66 (95% Confidence Interval (CI) (1.26-2.19)) and 1.81 (95%CI (1.34-2.45)) respectively. As for 30-day mortality, it was significantly lower among patients on steroid (OR=0.41; 95%CI (0.19-0.86)). Comparing UC to CD, anastomotic leaks were less common among UC patients (OR=0.53; 95%CI (0.37-0.76)), but 30-day mortality was significantly more prevalent among UC patients (OR=8.11; 95%CI (4.22-15.6)).
CONCLUSION: Among IBD patients undergoing colectomy, major surgical complications except 30-day mortality appear to increase with the use of preoperative steroids. © Acta Gastro-Enterologica Belgica.

Entities:  

Keywords:  Crohn's disease; colectomy; inflammatory bowel disease; outcomes; ulcerative colitis

Mesh:

Substances:

Year:  2018        PMID: 30350526

Source DB:  PubMed          Journal:  Acta Gastroenterol Belg        ISSN: 1784-3227            Impact factor:   1.316


  3 in total

1.  Trends and Outcomes of Hip Fracture Hospitalization Among Medicare Beneficiaries with Inflammatory Bowel Disease, 2000-2017.

Authors:  Fang Xu; Anne G Wheaton; Kamil E Barbour; Yong Liu; Kurt J Greenlund
Journal:  Dig Dis Sci       Date:  2020-07-22       Impact factor: 3.199

Review 2.  Prehabilitation prior to intestinal resection in Crohn's disease patients: An opinion review.

Authors:  Michiel T J Bak; Marit F E Ruiterkamp; Oddeke van Ruler; Marjo J E Campmans-Kuijpers; Bart C Bongers; Nico L U van Meeteren; C Janneke van der Woude; Laurents P S Stassen; Annemarie C de Vries
Journal:  World J Gastroenterol       Date:  2022-06-14       Impact factor: 5.374

3.  Risk of postoperative infectious complications from medical therapies in inflammatory bowel disease.

Authors:  Cindy Cy Law; Conor Bell; Deborah Koh; Yueyang Bao; Vipul Jairath; Neeraj Narula
Journal:  Cochrane Database Syst Rev       Date:  2020-10-24
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.